英语翻译

The news that a Massachusetts company, Advanced Cell Technology (ACT), had found a way to generate embryonic stem cells without destroying the embryo from which the cells came has already predictably raised the hopes of stem cell research supporters. But while ACT enjoyed a nearly 360% jump in its stock price after the news was reported Wednesday in the journal Nature, it's not at all clear that its achievement, while noteworthy for scientific reasons, has actually succeeded in resolving any of the ethical and moral objections — or even the legislative restrictions — to embryonic stem cell research.

 

有新闻称，来自麻省的公司----先进细胞技术(ACT)已经找到了不必破坏胚胎源细胞从而获得胚胎干细胞的方法。这则新闻可以想象到地唤起了胚胎干细胞研究支持者们的希望。这则新闻周三的时候在自然杂志上发表，之后，ACT公司正在享受他们的股票将近360%的升值所带来的喜悦时，他们还没有清楚地认识到他们的成果，尽管很显然是出于科学研究的动机，是不是已经成功地解决了胚胎干细胞研究的伦理道德上的反对意见，甚至解决了包括法律上的限制。